Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Sanofi”

A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the PhilippinesCompleted
NCT01949675Phase 4Updated Mar 23, 2018
Sponsor: Sanofi Pasteur, a Sanofi Company
Cholera
Philippines
Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of AgeCompleted
NCT02610348NAUpdated Mar 20, 2018
Sponsor: Sanofi Pasteur, a Sanofi Company
Hepatitis B
Thailand
Comparative Study of Immunogenicity and Safety of Flu-ID Vaccine Versus Flu-IM VaccineCompleted
NCT00554333Phase 3Updated Mar 16, 2018
Sponsor: Sanofi Pasteur, a Sanofi Company
Influenza
Belgium, France
Local Excision in Downstaged Rectal CancerCompleted
NCT00427375Phase 3Updated Mar 14, 2018
Sponsor: University Hospital, Bordeaux
Rectal Neoplasms
France
An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract SymptomsCompleted
NCT00893113Phase 3Updated Mar 9, 2018
Sponsor: Chesapeake Urology Research Associates
Erectile Dysfunction · Lower Urinary Tract Symptoms
United States
Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung CancerTerminated
NCT00268151Phase 1Updated Mar 5, 2018
Sponsor: University of Louisville
Carcinoma, Non-Small Cell Lung
United States
Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration TrialCompleted
NCT00995293Phase 3Updated Mar 2, 2018
Sponsor: Sanofi
Head and Neck Neoplasms
China
Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult SubjectsCompleted
NCT00730288Phase 2Updated Feb 27, 2018
Sponsor: Sanofi
Dengue · Dengue Fever · Dengue Hemorrhagic Fever · Dengue Virus
Australia
Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction AdenocarcinomaCompleted
NCT00183872Phase 2Updated Feb 19, 2018
Sponsor: University of Southern California
Gastric Cancer · Esophageal Neoplasms
United States
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute LeukemiasTerminated
NCT00852709Phase 1Updated Feb 15, 2018
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Myelodysplastic Syndrome · Acute Myeloid Leukemia · Myeloproliferative Disorders · Acute Lymphocytic Leukemia
United States, Canada
Benefit/Risk Evaluation of Insuman Implantable Versus Insuplant Using Medtronic MiniMed Implantable Pump System in Patients With Type 1 DiabetesCompleted
NCT01194882Phase 3Updated Feb 15, 2018
Sponsor: Sanofi
Diabetes Mellitus, Type 1
Belgium, France, Netherlands, Sweden
Comparison of Purified Vero Rabies Vaccine, Serum Free With Human Diploid Cell Vaccine in Pre-exposure UseCompleted
NCT01784874Phase 2Updated Feb 9, 2018
Sponsor: Sanofi Pasteur, a Sanofi Company
Rabies
United States
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and OlderCompleted
NCT02553343Phase 2Updated Feb 9, 2018
Sponsor: Sanofi Pasteur, a Sanofi Company
Influenza
United States
Autologous CD117+ Progenitor Cell Mobilization for Lung TransplantationCompleted
NCT01916577Phase 1Updated Feb 8, 2018
Sponsor: University of Colorado, Denver
COPD · Cystic Fibrosis · Pulmonary Fibrosis
United States
Safety and Immunogenicity of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in ToddlersCompleted
NCT00631995Phase 1Updated Feb 6, 2018
Sponsor: Sanofi Pasteur, a Sanofi Company
Meningitis · Meningococcal Infection
Australia
Lenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)Completed
NCT01373229Phase 1Updated Feb 5, 2018
Sponsor: David Rizzieri, MD
Leukemia, Lymphocytic, Chronic, B-Cell
United States
Study of Capecitabine and Cyclophosphamide Administered as a Single Pill in Patients With Advanced Breast CancerCompleted
NCT02664103Phase 2Updated Feb 1, 2018
Sponsor: Sanofi
Breast Cancer Metastatic
India
A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)Completed
NCT02373202Phase 3Updated Jan 30, 2018
Sponsor: Sanofi
Rheumatoid Arthritis
Japan
A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI)Completed
NCT02293902Phase 3Updated Jan 30, 2018
Sponsor: Sanofi
Rheumatoid Arthritis
Japan
Oxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal and Gastroesophageal (GE) Junction CarcinomaTerminated
NCT00256269Phase 2Updated Jan 26, 2018
Sponsor: University of California, Irvine
Esophageal Cancer · Gastroesophageal Cancer
United States
SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) PatientsCompleted
NCT01472887Phase 2Updated Jan 25, 2018
Sponsor: Sanofi
Diffuse Large B-cell Lymphoma
United States, Belgium, Czechia, Israel, Italy +4 more
A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal CancerCompleted
NCT00500292Phase 2Updated Jan 25, 2018
Sponsor: Genzyme, a Sanofi Company
Colorectal · Cancer
France, Hungary, Slovakia, South Korea, Spain +1 more
Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior ChemotherapyCompleted
NCT00364351Phase 3Updated Jan 25, 2018
Sponsor: Genzyme, a Sanofi Company
Non Small Cell Lung Cancer
United States, Argentina, Australia, Brazil, Canada +17 more
A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet)Terminated
NCT02166658Phase 2Updated Jan 23, 2018
Sponsor: AIO-Studien-gGmbH
Breast Cancer · Lung Cancer · Recurrent Brain Metastases · Progressive Brain Metastases
Germany
Phase I/II Cabazitaxel for Recurrent Malignant GliomaWithdrawn
NCT01740570Phase 1, Phase 2Updated Jan 19, 2018
Sponsor: M.D. Anderson Cancer Center
Brain Cancer

Previous page Next page